Skip to main content
CB

CEPHA Biotech

CEPHA Biotech develops custom molecular diagnostic assays, including LAMP-based solutions, to provide accessible DNA analysis for researchers and organizations. They translate scientific knowledge into tailored protocols, enabling clients to obtain specific genetic insights without requiring in-house molecular biology expertise.

Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Access to advanced molecular diagnostic testing, particularly DNA analysis, is often limited by the need for specialized laboratory infrastructure and expertise. This creates a bottleneck for researchers and organizations requiring tailored genetic insights for various applications.

Solution

CEPHA Biotech provides custom molecular diagnostic solutions, enabling decentralized and democratized access to advanced DNA analysis. The company translates scientific knowledge into bespoke testing protocols, allowing clients to obtain specific genetic information without requiring in-house molecular biology capabilities. This approach facilitates the application of molecular insights across diverse fields by making sophisticated DNA analysis more accessible and adaptable to unique research or diagnostic requirements.

Target Audience

CEPHA Biotech serves researchers, academic institutions, and organizations requiring custom molecular diagnostic capabilities for their specific projects and applications.

Features

  • Development of custom molecular diagnostic assays based on client-specific requirements.
  • Utilization of LAMP (Loop-mediated Isothermal Amplification) technology for rapid, point-of-need molecular detection.
  • Translation of scientific literature and research findings into validated diagnostic protocols.
  • Provision of tailored DNA analysis services for research and development applications.
This profile is AI-generated and may contain inaccuracies.